Novavax, Inc. (NASDAQ: NVAX) today announced that it has priced an underwritten public offering of 6,800,000 shares of its common stock at a ...
ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has priced an underwritten public offering of 6,800,000 shares of its common stock at a price to the public of $3.30 per share. The approximately $21 million of net proceeds, after deducting the underwriting discounts and commissions, will be used for preclinical studies and clinical trials of our VLP-based vaccines, internal research and development programs, working capital, capital expenditures and other general corporate purposes. The offering is expected to close on or about November 25, 2009, subject to the satisfaction of ...
Novavax, Inc. (NASDAQ: NVAX) today announced that it ...
ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it intends to offer shares of its common stock in an underwritten public offering. Piper Jaffray & Co. and Lazard Capital Markets LLC are acting as joint book running managers. The offering is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. Copies of the final prospectus supplement and accompanying prospectus relating to the offering ...
Pali Research upgrades Lazard (NYSE: LAZ) from Neutral to Buy.
Pali analyst says, "Restructuring, while expected to slow given the strong pace ofclosings in Q2 and Q3 remains healthy. The outlook ...
-
Veeco Upcoming Investor Events
-
Credit Suisse/Tremont Hedge Fund Index Finishes Relatively Flat in October, Up 0.13% for the Month and 15.11% Year-to-Date
-
Comverge (COMV) Prices 2.4M Shares at $10.50/Share
-
Comverge Announces Pricing of Underwritten Offering of Common Stock
-
Affymax (AFFY) Prices 4.1M Shares at $18.25/Share
-
Supertex to Present at the Lazard Capital Markets 2nd Annual LED Conference
-
Affymax Prices Public Offering of Common Stock
-
Form 8-K Lazard Group LLC For: Nov 16
-
Form 8-K Lazard Ltd For: Nov 16
-
Affymax (AFFY) Announces Intentions to Offer Common Stock
-
Affymax Announces Proposed Public Offering of Common Stock
-
Lazard World Dividend & Income Fund Declares Monthly Distribution
-
Lazard Global Total Return & Income Fund Declares Monthly Dividend
-
Simon Property (SPG) Mulls Bid for General Growth Properties (GGWPQ)
-
General Growth Properties (GGWPQ) Surges On Reports Of Simon Properties (SPG) Bid
-
AGA Medical Adds Jack P. Helms to Board of Directors
-
Form 4 Lazard Ltd For: Nov 13 Filed by: Mignon Laurent
-
Form 4 Lazard Ltd For: Nov 13 Filed by: Jones Ellis
-
Form 4 Lazard Ltd For: Nov 13 Filed by: HEYER STEVEN J
-
Lazard's (LAZ) Jacobs to Follow in Wasserstein's Footsteps
-
Lazard (LAZ) Jumps Higher Amid Intraday Oppenheimer Upgrade
-
PharMerica to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
-
BMP Sunstone to Present at LCM Healthcare Conference
-
Lazard (LAZ) Names Ken Jacobs as Chairman, CEO
-
BioSante Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference
-
Lazard Names Kenneth M. Jacobs Chairman and Chief Executive Officer
-
Cardo Medical to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
-
Amgen to Present at Lazard Capital Healthcare Conference
-
DexCom To Present at Lazard Capital Markets 6th Annual Healthcare Conference
-
Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
-
Health Management Associates, Inc. to Present at the Lazard Capital Markets Sixth Annual Healthcare Conference
-
Theratechnologies to Present at Lazard Capital Markets Conference
-
Theratechnologies to Present at Lazard Capital Markets Conference
-
Exact Sciences to Present at Lazard Healthcare Conference
-
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
-
Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit on Behalf of RH Donnelley Investors
-
Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
-
OPKO Health to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
-
Threshold to Present at Lazard Capital Markets Healthcare Conference
-
Lazard Capital Downgrades Shire Ltd. (SHPGY) to Hold
-
Lux Biosciences to Present at Lazard Capital Markets 6th Annual Healthcare Conference
-
Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
-
Geron to Present at LCM Healthcare Conference
-
Delcath Systems to Present at Lazard Capital Markets 6th Annual Healthcare Conference
-
Quest Diagnostics to Speak at the Lazard Capital Markets 6th Annual Healthcare Conference
-
Celgene Corporation to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
-
King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
-
Form SC 13G/A RMR Asia Pacific Real Filed by: LAZARD ASSET MANAGEMENT LLC
-
AcelRx to Present at the Lazard 6th Annual Healthcare Conference
-
AspenBio to Present at the Lazard Capital Market 6th Annual Healthcare Conference
